{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:45:05Z","timestamp":1787496305953,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-022-04768-2","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T10:03:21Z","timestamp":1672740201000},"page":"2077-2088","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Diuretics in pediatrics"],"prefix":"10.1007","volume":"182","author":[{"given":"Sebastiano A. G.","family":"Lava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Zollinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassib","family":"Chehade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Schaffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Sekarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Di Bernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,3]]},"reference":[{"issue":"8","key":"4768_CR1","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.2215\/CJN.09630818","volume":"14","author":"DH Ellison","year":"2019","unstructured":"Ellison DH (2019) Clinical pharmacology in diuretic use. Clin J Am Soc Nephrol 14(8):1248\u20131257. https:\/\/doi.org\/10.2215\/CJN.09630818","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"4768_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2165\/00148581-200608040-00004","volume":"8","author":"MM van der Vorst","year":"2006","unstructured":"van der Vorst MM, Kist JE, van der Heijden AJ, Burggraaf J (2006) Diuretics in pediatrics\u202f: current knowledge and future prospects. Paediatr Drugs 8(4):245\u2013264. https:\/\/doi.org\/10.2165\/00148581-200608040-00004","journal-title":"Paediatr Drugs"},{"issue":"9","key":"4768_CR3","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1007\/s00467-021-04921-3","volume":"36","author":"JP Guignard","year":"2021","unstructured":"Guignard JP, Iacobelli S (2021) Use of diuretics in the neonatal period. Pediatr Nephrol 36(9):2687\u20132695. https:\/\/doi.org\/10.1007\/s00467-021-04921-3","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"4768_CR4","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jaad.2018.12.006","volume":"80","author":"WR Heymann","year":"2019","unstructured":"Heymann WR (2019) The expanding saga of hydrochlorothiazide and skin cancer. J Am Acad Dermatol 80(2):380\u2013381. https:\/\/doi.org\/10.1016\/j.jaad.2018.12.006","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"4768_CR5","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1111\/bcp.15367","volume":"88","author":"A Piffer","year":"2022","unstructured":"Piffer A, Bianchetti MG, Leoni-Foglia C, Simonetti GD, Milani GP, Lava SAG (2022) Vaptans for oedematous and hyponatraemic disorders in childhood: a systematic literature review. Br J Clin Pharmacol 88(10):4474\u20134480. https:\/\/doi.org\/10.1111\/bcp.15367","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"4768_CR6","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s40265-019-01148-3","volume":"79","author":"S Dhillon","year":"2019","unstructured":"Dhillon S (2019) Dapagliflozin: a review in type 2 diabetes. Drugs 79(10):1135\u20131146. https:\/\/doi.org\/10.1007\/s40265-019-01148-3","journal-title":"Drugs"},{"issue":"2","key":"4768_CR7","doi-asserted-by":"publisher","first-page":"44A","DOI":"10.1016\/0002-9149(86)91006-4","volume":"57","author":"MK Witte","year":"1986","unstructured":"Witte MK, Stork JE, Blumer JL (1986) Diuretic therapeutics in the pediatric patient. Am J Cardiol 57(2):44A\u201353A. https:\/\/doi.org\/10.1016\/0002-9149(86)91006-4","journal-title":"Am J Cardiol"},{"issue":"4","key":"4768_CR8","doi-asserted-by":"publisher","first-page":"F313","DOI":"10.1136\/adc.2006.108860","volume":"93","author":"NE Moghal","year":"2008","unstructured":"Moghal NE, Shenoy M (2008) Furosemide and acute kidney injury in neonates. Arch Dis Child Fetal Neonatal Ed 93(4):F313-316. https:\/\/doi.org\/10.1136\/adc.2006.108860","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"12","key":"4768_CR9","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.cjca.2013.08.008","volume":"29","author":"Kantor PF, Lougheed J, Dancea A, McGillion M, Barbosa N, Chan C, Dillenburg R, Atallah J, Buchholz H, Chant-Gambacort C, Conway J, Gardin L, George K, Greenway S, Human DG, Jeewa A, Price JF, Ross RD, Roche SL, Ryerson L, Soni R, Wilson J, Wong K; Children's Heart Failure Study Group","year":"2013","unstructured":"Kantor PF, Lougheed J, Dancea A, McGillion M, Barbosa N, Chan C, Dillenburg R, Atallah J, Buchholz H, Chant-Gambacort C, Conway J, Gardin L, George K, Greenway S, Human DG, Jeewa A, Price JF, Ross RD, Roche SL, Ryerson L, Soni R, Wilson J, Wong K, Children\u2019s Heart Failure Study Group (2013) Presentation, diagnosis, and medical management of heart failure in children: Canadian cardiovascular society guidelines. Can J Cardiol 29(12):1535\u20131552. https:\/\/doi.org\/10.1016\/j.cjca.2013.08.008","journal-title":"Can J Cardiol"},{"issue":"4","key":"4768_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00431-016-2700-3","volume":"175","author":"D Schranz","year":"2016","unstructured":"Schranz D, Voelkel NF (2016) \u201cNihilism\u201d of chronic heart failure therapy in children and why effective therapy is withheld. Eur J Pediatr 175(4):445\u2013455. https:\/\/doi.org\/10.1007\/s00431-016-2700-3","journal-title":"Eur J Pediatr"},{"key":"4768_CR11","doi-asserted-by":"publisher","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341(10):709\u2013717. https:\/\/doi.org\/10.1056\/NEJM199909023411001","DOI":"10.1056\/NEJM199909023411001"},{"issue":"16","key":"4768_CR12","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1161\/CIR.0b013e31829e8776","volume":"128","author":"WRITING COMMITTEE MEMBERS, Yancy CW","year":"2013","unstructured":"Writing committee members, Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL (2013)\u00a02013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation 128(16):e240-327.\u00a0https:\/\/doi.org\/10.1161\/CIR.0b013e31829e8776","journal-title":"Circulation"},{"issue":"6","key":"4768_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1024\/0040-5930.57.6r.355","volume":"57","author":"B Vogt","year":"2000","unstructured":"Vogt B, Reichen J (2000) Rationale Diuretikatherapie bei Patienten mit Leberzirrhose [Rational diuretic therapy in patients with liver cirrhosis]. Ther Umsch 57(6):355\u2013360. https:\/\/doi.org\/10.1024\/0040-5930.57.6r.355","journal-title":"Ther Umsch"},{"issue":"28","key":"4768_CR14","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.3748\/wjg.v25.i28.3738","volume":"25","author":"DV Garbuzenko","year":"2019","unstructured":"Garbuzenko DV, Arefyev NO (2019) Current approaches to the management of patients with cirrhotic ascites. World J Gastroenterol 25(28):3738\u20133752. https:\/\/doi.org\/10.3748\/wjg.v25.i28.3738","journal-title":"World J Gastroenterol"},{"issue":"8","key":"4768_CR15","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1097\/HJH.0000000000002088","volume":"37","author":"M Burnier","year":"2019","unstructured":"Burnier M, Bakris G, Williams B (2019) Redefining diuretics use in hypertension: why select a thiazide-like diuretic? J Hypertens 37(8):1574\u20131586. https:\/\/doi.org\/10.1097\/HJH.0000000000002088","journal-title":"J Hypertens"},{"issue":"12","key":"4768_CR16","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1007\/s00467-016-3334-4","volume":"31","author":"DL Blowey","year":"2016","unstructured":"Blowey DL (2016) Diuretics in the treatment of hypertension. Pediatr Nephrol 31(12):2223\u20132233. https:\/\/doi.org\/10.1007\/s00467-016-3334-4","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"4768_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003088-199834010-00001","volume":"34","author":"H Knauf","year":"1998","unstructured":"Knauf H, Mutschler E (1998) Clinical pharmacokinetics and pharmacodynamics of torasemide. Clin Pharmacokinet 34(1):1\u201324. https:\/\/doi.org\/10.2165\/00003088-199834010-00001","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"4768_CR18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1136\/archdischild-2013-305818","volume":"99","author":"MO Babiker","year":"2014","unstructured":"Babiker MO, Prasad M, MacLeod S, Chow G, Whitehouse WP (2014) Fifteen-minute consultation: the child with idiopathic intracranial hypertension. Arch Dis Child Educ Pract Ed 99(5):166\u2013172. https:\/\/doi.org\/10.1136\/archdischild-2013-305818","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"4768_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jpeds.2020.10.073","volume":"231","author":"NA Bamat","year":"2021","unstructured":"Bamat NA, Nelin TD, Eichenwald EC, Kirpalani H, Laughon MM, Jackson WM, Jensen EA, Gibbs KA, Lorch SA (2021) Loop diuretics in severe bronchopulmonary dysplasia: cumulative use and associations with mortality and age at discharge. J Pediatr 231:43-49.e3. https:\/\/doi.org\/10.1016\/j.jpeds.2020.10.073","journal-title":"J Pediatr"},{"issue":"8","key":"4768_CR20","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1111\/jpc.14877","volume":"56","author":"C Tan","year":"2020","unstructured":"Tan C, Sehgal K, Sehgal K, Krishnappa SB, Sehgal A (2020) Diuretic use in infants with developing or established chronic lung disease: a practice looking for evidence. J Paediatr Child Health 56(8):1189\u20131193. https:\/\/doi.org\/10.1111\/jpc.14877","journal-title":"J Paediatr Child Health"},{"issue":"5","key":"4768_CR21","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1002\/ppul.24722","volume":"55","author":"JL Segar","year":"2020","unstructured":"Segar JL (2020) Rethinking furosemide use for infants with bronchopulmonary dysplasia. Pediatr Pulmonol 55(5):1100\u20131103. https:\/\/doi.org\/10.1002\/ppul.24722","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"4768_CR22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1024\/0040-5930.57.6.345","volume":"57","author":"P Ferrari","year":"2000","unstructured":"Ferrari P, Frey FJ (2000) Angriffspunkte der Diuretika in der Niere [Pharmacologic action of diuretics in the kidney]. Ther Umsch 57(6):345\u2013350. https:\/\/doi.org\/10.1024\/0040-5930.57.6.345","journal-title":"Ther Umsch"},{"issue":"7","key":"4768_CR23","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s004670050514","volume":"12","author":"SK Eades","year":"1998","unstructured":"Eades SK, Christensen ML (1998) The clinical pharmacology of loop diuretics in the pediatric patient. Pediatr Nephrol 12(7):603\u2013616. https:\/\/doi.org\/10.1007\/s004670050514","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"4768_CR24","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1056\/NEJMra035092","volume":"349","author":"GL Kearns","year":"2003","unstructured":"Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE (2003) Developmental pharmacology\u2013drug disposition, action, and therapy in infants and children. N Engl J Med 349(12):1157\u20131167. https:\/\/doi.org\/10.1056\/NEJMra035092","journal-title":"N Engl J Med"},{"issue":"20","key":"4768_CR25","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1056\/NEJMra1703100","volume":"377","author":"DH Ellison","year":"2017","unstructured":"Ellison DH, Felker GM (2017) Diuretic treatment in heart failure. N Engl J Med 377(20):1964\u20131975. https:\/\/doi.org\/10.1056\/NEJMra1703100","journal-title":"N Engl J Med"},{"issue":"11","key":"4768_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11886-020-01384-0","volume":"22","author":"WHW Tang","year":"2020","unstructured":"Tang WHW, Kiang A (2020) Acute cardiorenal syndrome in heart failure: from dogmas to advances. Curr Cardiol Rep 22(11):143. https:\/\/doi.org\/10.1007\/s11886-020-01384-0","journal-title":"Curr Cardiol Rep"},{"key":"4768_CR27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-physiol-031620-095920","volume":"83","author":"V Vallon","year":"2021","unstructured":"Vallon V, Verma S (2021) Effects of SGLT2 inhibitors on kidney and cardiovascular function. Annu Rev Physiol 83:503\u2013528. https:\/\/doi.org\/10.1146\/annurev-physiol-031620-095920","journal-title":"Annu Rev Physiol"},{"key":"4768_CR28","doi-asserted-by":"publisher","unstructured":"Van Siang Lian Mang P, Hui JC, Tan RSJ, Hasan MS, Choo YM, Abosamak MF, Ng KT (2022) The diuretic effect of adding aminophylline or theophylline to furosemide in pediatric populations: a systematic review. Eur J Pediatr.\u00a0https:\/\/doi.org\/10.1007\/s00431-022-04655-w. Epub ahead of print","DOI":"10.1007\/s00431-022-04655-w"},{"issue":"4","key":"4768_CR29","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1161\/HYPERTENSIONAHA.120.15205","volume":"76","author":"CS Wilcox","year":"2020","unstructured":"Wilcox CS, Testani JM, Pitt B (2020) Pathophysiology of diuretic resistance and its implications for the management of chronic heart failure. Hypertension 76(4):1045\u20131054. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.15205","journal-title":"Hypertension"},{"issue":"4","key":"4768_CR30","doi-asserted-by":"publisher","first-page":"262","DOI":"10.7326\/0003-4819-159-4-201308200-00007","volume":"159","author":"D Vasilakou","year":"2013","unstructured":"Vasilakou D, Karagiannis T, Athanasiadou E, Mainou M, Liakos A, Bekiari E, Sarigianni M, Matthews DR, Tsapas A (2013) Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med 159(4):262\u2013274. https:\/\/doi.org\/10.7326\/0003-4819-159-4-201308200-00007","journal-title":"Ann Intern Med"},{"issue":"11","key":"4768_CR31","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S2213-8587(19)30256-6","volume":"7","author":"BL Neuen","year":"2019","unstructured":"Neuen BL, Young T, Heerspink HJL, Neal B, Perkovic V, Billot L, Mahaffey KW, Charytan DM, Wheeler DC, Arnott C, Bompoint S, Levin A, Jardine MJ (2019) SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 7(11):845\u2013854. https:\/\/doi.org\/10.1016\/S2213-8587(19)30256-6","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10254","key":"4768_CR32","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","volume":"396","author":"F Zannad","year":"2020","unstructured":"Zannad F, Ferreira JP, Pocock SJ, Anker SD, Butler J, Filippatos G, Brueckmann M, Ofstad AP, Pfarr E, Jamal W, Packer M (2020) SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials. Lancet 396(10254):819\u2013829. https:\/\/doi.org\/10.1016\/S0140-6736(20)31824-9","journal-title":"Lancet"},{"issue":"21","key":"4768_CR33","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1056\/NEJMra2115011","volume":"386","author":"E Braunwald","year":"2022","unstructured":"Braunwald E (2022) Gliflozins in the management of cardiovascular disease. N Engl J Med 386(21):2024\u20132034. https:\/\/doi.org\/10.1056\/NEJMra2115011","journal-title":"N Engl J Med"},{"issue":"12","key":"4768_CR34","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.cardfail.2021.07.003","volume":"27","author":"P Bjornstad","year":"2021","unstructured":"Bjornstad P, Greasley PJ, Wheeler DC, Chertow GM, Langkilde AM, Heerspink HJL, Van Raalte DH (2021) The potential roles of osmotic and nonosmotic sodium handling in mediating the effects of sodium-glucose cotransporter 2 inhibitors on heart failure. J Card Fail 27(12):1447\u20131455. https:\/\/doi.org\/10.1016\/j.cardfail.2021.07.003","journal-title":"J Card Fail"},{"key":"4768_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.800490","volume":"13","author":"J Tang","year":"2022","unstructured":"Tang J, Ye L, Yan Q, Zhang X, Wang L (2022) Effects of sodium-glucose cotransporter 2 inhibitors on water and sodium metabolism. Front Pharmacol 13:800490. https:\/\/doi.org\/10.3389\/fphar.2022.800490","journal-title":"Front Pharmacol"},{"issue":"6","key":"4768_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2021.101285","volume":"47","author":"P Delanaye","year":"2021","unstructured":"Delanaye P, Scheen AJ (2021) The diuretic effects of SGLT2 inhibitors: a comprehensive review of their specificities and their role in renal protection. Diabetes Metab 47(6):101285. https:\/\/doi.org\/10.1016\/j.diabet.2021.101285","journal-title":"Diabetes Metab"},{"issue":"2","key":"4768_CR37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/01.mnh.0000441151.55320.c3","volume":"23","author":"J Titze","year":"2014","unstructured":"Titze J (2014) Sodium balance is not just a renal affair. Curr Opin Nephrol Hypertens 23(2):101\u2013105. https:\/\/doi.org\/10.1097\/01.mnh.0000441151.55320.c3","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"4768_CR38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12933-017-0654-z","volume":"17","author":"MV Karg","year":"2018","unstructured":"Karg MV, Bosch A, Kannenkeril D, Striepe K, Ott C, Schneider MP, Boemke-Zelch F, Linz P, Nagel AM, Titze J, Uder M, Schmieder RE (2018) SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial. Cardiovasc Diabetol 17(1):5. https:\/\/doi.org\/10.1186\/s12933-017-0654-z","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"4768_CR39","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S2213-8587(22)00052-3","volume":"10","author":"WV Tamborlane","year":"2022","unstructured":"Tamborlane WV et al (2022) Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study. Lancet Diabetes Endocrinol 10(5):341\u2013350. https:\/\/doi.org\/10.1016\/S2213-8587(22)00052-3","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"4768_CR40","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1007\/s00467-022-05456-x","volume":"37","author":"AJ Kula","year":"2022","unstructured":"Kula AJ (2022) Considerations and possibilities for sodium-glucose cotransporter 2 inhibitors in pediatric CKD. Pediatr Nephrol 37(10):2267\u20132276. https:\/\/doi.org\/10.1007\/s00467-022-05456-x","journal-title":"Pediatr Nephrol"},{"key":"4768_CR41","doi-asserted-by":"publisher","unstructured":"Newland DM, Law YM, Albers EL, Friedland-Little JM, Ahmed H, Kemna MS, Hong BJ (2022) Early clinical experience with dapagliflozin in children with heart failure. Pediatr Cardiol.\u00a0https:\/\/doi.org\/10.1007\/s00246-022-02983-0. Epub ahead of print","DOI":"10.1007\/s00246-022-02983-0"},{"key":"4768_CR42","doi-asserted-by":"publisher","unstructured":"Pedersen SA, Johannesdottir Schmidt SA, H\u00f6lmich LR, Friis S, Potteg\u00e5rd A, Gaist D (2019) Hydrochlorothiazide use and risk for Merkel cell carcinoma and malignant adnexal skin tumors: a nationwide case-control study.\u00a0J Am Acad Dermatol 80(2):460\u2013465.e9.\u00a0https:\/\/doi.org\/10.1016\/j.jaad.2018.06.014","DOI":"10.1016\/j.jaad.2018.06.014"},{"issue":"10","key":"4768_CR43","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1097\/HJH.0000000000002136","volume":"37","author":"R Kreutz","year":"2019","unstructured":"Kreutz R, Algharably EAH, Douros A (2019) Reviewing the effects of thiazide and thiazide-like diuretics as photosensitizing drugs on the risk of skin cancer. J Hypertens 37(10):1950\u20131958. https:\/\/doi.org\/10.1097\/HJH.0000000000002136","journal-title":"J Hypertens"},{"key":"4768_CR44","doi-asserted-by":"publisher","unstructured":"Commander SJ, Wu H, Boakye-Agyeman F, Melloni C, Hornik CD, Zimmerman K, Al-Uzri A, Mendley SR, Harper B, Cohen-Wolkowiez M, Hornik CP (2021) Best Pharmaceuticals for children act-pediatric trials network steering committee. Pharmacokinetics of hydrochlorothiazide in children: a potential surrogate for renal secretion maturation.\u00a0J Clin Pharmacol 61(3):368\u2013377.\u00a0https:\/\/doi.org\/10.1002\/jcph.1739","DOI":"10.1002\/jcph.1739"},{"issue":"8","key":"4768_CR45","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/jps.2600730821","volume":"73","author":"AA Holazo","year":"1984","unstructured":"Holazo AA, Colburn WA, Gustafson JH, Young RL, Parsonnet M (1984) Pharmacokinetics of bumetanide following intravenous, intramuscular, and oral administrations to normal subjects. J Pharm Sci 73(8):1108\u20131113. https:\/\/doi.org\/10.1002\/jps.2600730821","journal-title":"J Pharm Sci"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-022-04768-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-022-04768-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-022-04768-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T06:34:32Z","timestamp":1683786872000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-022-04768-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,3]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["4768"],"URL":"https:\/\/doi.org\/10.1007\/s00431-022-04768-2","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,3]]},"assertion":[{"value":"6 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable (narrative review study).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable (narrative review study).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"\u00a0All authors gave their consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}